An unconfirmed report has claimed that two students at the Indian Hills Elementary School in Jurupa Valley, California, have been diagnosed with leprosy. On Friday, Jurupa Unified School District officials informed parents of the case, as a precaution.
Earlier on Friday, a school nurse notified officials of an infection. Barbara Cole, director for disease control for the Riverside County Department of Public Health, did not confirm the information, emphasizing that they are at the beginning of an investigation into the claims. Test results can take several weeks. Meanwhile, intensive cleaning was done at the school over the weekend, but no further precautions were taken. It is known that the students at issue are not currently in school. Chitpur Leprosy Clinic © Flickr/ Calcutta Rescue World’s First Leprosy Vaccine to Enter Trials in India According to the US Centers for Disease Control and Prevention, leprosy is transmitted from person to person through respiratory droplets and family members are most at risk for catching the disease. Some parents did not send their children to school on Tuesday, though it is considered that healthy people are normally not vulnerable to leprosy, and the initial stages of the dis
India plans to launch a mass vaccination program against leprosy, the first of its kind in the world.
The Aedes Aegypti mosquito is photographed in a lab at the Ministry of Health of El Salvador, in San Salvador © AFP 2016/ MARVIN RECINOS US Begins Human Clinical Trials of Zika Vaccine New Delhi(Sputnik) – The vaccine, a mycobacterium indicus pranii (MIP) developed by the National Institute of Immunology in New Delhi, will be administered as a preventive measure for people living in close contact with leprosy sufferers. This is expected to lend a major thrust to the National Leprosy Eradication Program — one of India’s most challenging health missions. The vaccine was developed by founder-director of the National Institute of Immunology (NII) G. P. Talwar, who said “An immunotherapeutic vaccine for leprosy has been approved by the Drug Controller General of India and US Food and Drug Administration. It is also effective for curing anogenital warts and some cancers.” The vaccination drive will be implemented on pilot basis starting next month in selected districts of the states of Bihar and Gujarat. According to various statistics, India has the largest number of leprosy patients in the world. The new vaccine is expected to lower the number of leprosy cases by 60 percent by the year 2020. Dr. Soumya Swaminathan, Director General of the Indian Council of Medical Research, says “a trial had shown that the vaccine, if given to people in close contact with affected persons, could bring down cases by 60 per cent in three years.” According to India’s Health Minister Jagat Prakash Nadda, although leprosy has been eradicated at the national level, there are 107 districts in India where Prevalence Rate (PR) is more than one in 10,000. This disease, caused by the bacteria Mycobacterium leprae, affects 125,000 Indians every year.